Acquiring French dietary supplements specialist Arkopharma Group in January helped Germany’s Dermapharm Holding to post a 10.8% rise in sales to €1.14bn ($1.23bn) in 2023.
Timely Acquisition Keeps Germany's Dermapharm Growing
With its Branded Pharmaceuticals division negatively impacted by the end of the COVID-19 pandemic, the timely acquisition of supplements firm Arkopharma ensured Dermapharm recorded double-digit sales growth in 2023.
